187 related articles for article (PubMed ID: 28926202)
1. Retinal dysfunction characterizes subtypes of dominant optic atrophy.
Cascavilla ML; Parisi V; Triolo G; Ziccardi L; Borrelli E; Di Renzo A; Balducci N; Lamperti C; Bianchi Marzoli S; Darvizeh F; Sadun AA; Carelli V; Bandello F; Barboni P
Acta Ophthalmol; 2018 Mar; 96(2):e156-e163. PubMed ID: 28926202
[TBL] [Abstract][Full Text] [Related]
2. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation.
Barboni P; Savini G; Cascavilla ML; Caporali L; Milesi J; Borrelli E; La Morgia C; Valentino ML; Triolo G; Lembo A; Carta A; De Negri A; Sadun F; Rizzo G; Parisi V; Pierro L; Bianchi Marzoli S; Zeviani M; Sadun AA; Bandello F; Carelli V
Am J Ophthalmol; 2014 Sep; 158(3):628-36.e3. PubMed ID: 24907432
[TBL] [Abstract][Full Text] [Related]
3. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
4. Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level.
Reis A; Mateus C; Viegas T; Florijn R; Bergen A; Silva E; Castelo-Branco M
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):221-34. PubMed ID: 22865259
[TBL] [Abstract][Full Text] [Related]
5. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG
Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995
[TBL] [Abstract][Full Text] [Related]
6. Macular function in eyes with open-angle glaucoma evaluated by multifocal electroretinogram.
Parisi V; Ziccardi L; Centofanti M; Tanga L; Gallinaro G; Falsini B; Bucci MG
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6973-80. PubMed ID: 22969069
[TBL] [Abstract][Full Text] [Related]
7. Early and localized retinal dysfunction in patients with type 1 diabetes mellitus studied by multifocal electroretinogram.
Ziccardi L; Parisi V; Picconi F; Di Renzo A; Lombardo M; Frontoni S; Parravano M
Acta Diabetol; 2018 Nov; 55(11):1191-1200. PubMed ID: 30159747
[TBL] [Abstract][Full Text] [Related]
8. Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age.
Barboni P; Savini G; Parisi V; Carbonelli M; La Morgia C; Maresca A; Sadun F; De Negri AM; Carta A; Sadun AA; Carelli V
Ophthalmology; 2011 Oct; 118(10):2076-80. PubMed ID: 21621262
[TBL] [Abstract][Full Text] [Related]
9. AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.
Amore G; Romagnoli M; Carbonelli M; Cascavilla ML; De Negri AM; Carta A; Parisi V; Di Renzo A; Schiavi C; Lenzetti C; Zenesini C; Ormanbekova D; Palombo F; Fiorini C; Caporali L; Carelli V; Barboni P; La Morgia C
Am J Ophthalmol; 2024 Jun; 262():114-124. PubMed ID: 38278202
[TBL] [Abstract][Full Text] [Related]
10. Multifocal VEP provide electrophysiological evidence of predominant dysfunction of the optic nerve fibers derived from the central retina in Leber's hereditary optic neuropathy.
Ziccardi L; Parisi V; Giannini D; Sadun F; De Negri AM; Barboni P; La Morgia C; Sadun AA; Carelli V
Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1591-600. PubMed ID: 25773998
[TBL] [Abstract][Full Text] [Related]
11. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
[TBL] [Abstract][Full Text] [Related]
12. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
Chun BY; Rizzo JF
Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
[TBL] [Abstract][Full Text] [Related]
13. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
14. Axonal loss occurs early in dominant optic atrophy.
Milea D; Sander B; Wegener M; Jensen H; Kjer B; Jørgensen TM; Lund-Andersen H; Larsen M
Acta Ophthalmol; 2010 May; 88(3):342-6. PubMed ID: 19302076
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod.
Barbano L; Ziccardi L; Landi D; Nicoletti CG; Mataluni G; Falsini B; Centonze D; Marfia GA; Quaranta L; Parisi V
Adv Ther; 2021 Jul; 38(7):3986-3996. PubMed ID: 34109558
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
[TBL] [Abstract][Full Text] [Related]
17. Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis.
Ziccardi L; Barbano L; Boffa L; Albanese M; Nicoletti CG; Landi D; Grzybowski A; Falsini B; Marfia GA; Centonze D; Parisi V
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33266435
[TBL] [Abstract][Full Text] [Related]
18. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
19. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations.
Miyata K; Nakamura M; Kondo M; Lin J; Ueno S; Miyake Y; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):820-4. PubMed ID: 17251483
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.
Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H
Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
